IBEX Limited announced record financial results for the third quarter of fiscal year 2025 on May 8, 2025. Quarterly revenue grew 11% year-over-year to $140.7 million, marking the highest growth in ten quarters.
The company achieved a record adjusted EPS of $0.82, an increase of 18% compared to the prior year quarter. IBEX also made a strategic entry into India, launching operations with a leading healthcare client, signaling geographic expansion.
The Board of Directors authorized a new $15 million share repurchase plan, demonstrating a commitment to returning value to shareholders. IBEX generated $3.6 million in free cash flow during the quarter and closed four new logos, bringing the year-to-date total to 12.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.